July 2023 | Media
News & Announcements
July 2023 | Media
July 2023 | Media
July 2023 | Statement
July 13, 2023 - Today, in a historic move for reproductive health that could transform contraception access, the United States Food and Drug Administration (FDA) approved Opill, a progestin-only birth control pill (POP), for over-the-counter (OTC) use. After a comprehensive review of the data and a...
June 2023 | Statement
June 26, 2023 – Last Friday, the Biden Administration issued an executive order on “Strengthening Access to Affordable, High-Quality Contraception and Family Planning Services” . The executive order includes an explicit directive to the Secretaries of the Treasury, Labor and HHS...
June 2023 | Statement
Cambridge, MA, June 23, 2023 – On June 24, 2022, The US Supreme Court released a final decision on Dobbs v. Jackson Women’s Health Organization , which eliminated constitutional protections of the right to abortion care established by Roe v. Wade in 1973. While the protections granted...
June 2023 | Statement
May 2023 | Blog
May 2023 | Statement
May 10, 2023 – Today, in a landmark step for reproductive health, a joint FDA advisory committee voted unanimously to allow a birth control pill to be offered over the counter (OTC). The advisory committee vote reflects the decades of science showing that birth control pills are safe and...